Balyasny Asset Management
USNA icon

Balyasny Asset Management’s Usana Health Sciences USNA Stock Holding History

Balyasny Asset Management’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$200K Sell
11,471
-19,285
-63% -$383K ﹤0.01% 2706
2025
Q4 		$604K Buy
+30,756
New +$638K ﹤0.01% 2438
2024
Q1 		– Sell
-13,934
Closed -$747K – 3148
2023
Q4 		$747K Buy
+13,934
New +$705K ﹤0.01% 1801
2023
Q2 		– Sell
-13,091
Closed -$823K – 2823
2023
Q1 		$823K Buy
+13,091
New +$781K ﹤0.01% 1809
2022
Q2 		– Sell
-9,765
Closed -$776K – 3210
2022
Q1 		$776K Buy
+9,765
New +$880K ﹤0.01% 1702
2021
Q3 		– Sell
-8,354
Closed -$856K – 2447
2021
Q2 		$856K Buy
8,354
+3,954
+90% +$397K ﹤0.01% 1358
2021
Q1 		$429K Buy
+4,400
New +$400K ﹤0.01% 1440
2020
Q1 		– Sell
-22,602
Closed -$1.77M – 1543
2019
Q4 		$1.77M Buy
22,602
+7,894
+54% +$582K 0.01% 778
2019
Q3 		$1.01M Buy
+14,708
New +$988K 0.01% 833
2019
Q2 		– Sell
-8,225
Closed -$690K – 1746
2019
Q1 		$690K Buy
+8,225
New +$859K ﹤0.01% 1118
2017
Q4 		– Sell
-5,250
Closed -$303K – 2337
2017
Q3 		$303K Buy
+5,250
New +$310K ﹤0.01% 1532

Other funds holding USNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Balyasny Asset Management's USNA Position: Q1 2026 in Review

Balyasny Asset Management reduced its Usana Health Sciences (USNA) stake by 63% in Q1 2026, selling an estimated $383K and leaving 11,471 shares worth $200K. The position accounts for ﹤0.01% of the portfolio, ranked #2706.

Balyasny Asset Management first reported a position in USNA in Q3 2017 and has held it in 11 quarters since. The position peaked at $1.77M in Q4 2019. 139 funds tracked by Wall St. Rank hold USNA as of Q1 2026.

  • Balyasny Asset Management held 11,471 shares of Usana Health Sciences worth $200K as of Q1 2026.
  • Balyasny Asset Management sold 19,285 Usana Health Sciences shares in Q1 2026, an estimated $383K.
  • Usana Health Sciences made up ﹤0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #2706 holding.
  • Balyasny Asset Management first reported a position in Usana Health Sciences in Q3 2017 and has held it in 11 quarters since.
  • Balyasny Asset Management's Usana Health Sciences position peaked at $1.77M in Q4 2019.
  • 139 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.